Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1982 1
1983 2
1984 1
1985 7
1986 7
1987 5
1988 12
1989 8
1990 3
1991 3
1992 4
1993 2
1994 4
1995 4
1996 1
1997 4
1998 2
1999 1
2001 1
2002 1
2003 1
2008 1
2009 1
2010 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of ophthalmic beta-blocking agents.
Lesar TS. Lesar TS. Clin Pharm. 1987 Jun;6(6):451-63. Clin Pharm. 1987. PMID: 2891463 Review.
However, betaxolol produces less systemic beta 2- and possibly beta 1-adrenergic receptor blockade than either timolol or levobunolol. Betaxolol may be relatively safer to use in patients with reactive airway disease than either timolol or levobunolol. ...Levobun …
However, betaxolol produces less systemic beta 2- and possibly beta 1-adrenergic receptor blockade than either timolol or levobunolol …
Levobunolol for the long-term treatment of glaucoma.
Novack GD. Novack GD. Gen Pharmacol. 1986;17(4):373-7. doi: 10.1016/0306-3623(86)90177-1. Gen Pharmacol. 1986. PMID: 3019819 Review.
Ocularly, levobunolol is as effective and as safe as topical timolol for the long-term treatment of elevated IOP. The utility of topical levobunolol as an additional, effective beta-blocker for the treatment of glaucoma will be determined by additional research and …
Ocularly, levobunolol is as effective and as safe as topical timolol for the long-term treatment of elevated IOP. The utility of topi …
Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
[No authors listed] [No authors listed] Ophthalmology. 1989 May;96(5):642-5. Ophthalmology. 1989. PMID: 2664628 Clinical Trial.
In a 4-year, double-masked, parallel, multicenter study comparing the efficacy and safety of levobunolol and timolol, 391 patients with open-angle glaucoma or ocular hypertension were randomly assigned to receive masked 0.5% or 1% levobunolol, or 0.5% timolol, twice …
In a 4-year, double-masked, parallel, multicenter study comparing the efficacy and safety of levobunolol and timolol, 391 patients wi …
Glaucoma treatment with once-daily levobunolol.
Wandel T, Charap AD, Lewis RA, Partamian L, Cobb S, Lue JC, Novack GD, Gaster R, Smith J, Duzman E. Wandel T, et al. Am J Ophthalmol. 1986 Mar 15;101(3):298-304. doi: 10.1016/0002-9394(86)90823-8. Am J Ophthalmol. 1986. PMID: 3513594 Clinical Trial.
Intraocular pressure decreases averaged 7.0 mm Hg with levobunolol 0.5%, 6.5 mm Hg with levobunolol 1%, and 4.5 mm Hg with timolol. The intraocular pressures of 72% (18 of 25 patients) of those treated with levobunolol 0.5%, 79% (22 of 28 patients) of those t …
Intraocular pressure decreases averaged 7.0 mm Hg with levobunolol 0.5%, 6.5 mm Hg with levobunolol 1%, and 4.5 mm Hg with tim …
Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort.
Krieglstein GK, Novack GD, Voepel E, Schwarzbach G, Lange U, Schunck KP, Lue JC, Glavinos EP. Krieglstein GK, et al. Br J Ophthalmol. 1987 Apr;71(4):250-3. doi: 10.1136/bjo.71.4.250. Br J Ophthalmol. 1987. PMID: 2883990 Free PMC article. Clinical Trial.
Topical levobunolol 0.5% was compared with topical metipranolol 0.6% for efficacy, safety, and comfort in 46 patients with open angle glaucoma or ocular hypertension. ...More complaints of burning and stinging were reported in the metipranolol group than in the levobuno …
Topical levobunolol 0.5% was compared with topical metipranolol 0.6% for efficacy, safety, and comfort in 46 patients with open angle …
A clinical evaluation of the effects of topically applied levobunolol and timolol on increased intraocular pressure.
Duzman E, Ober M, Scharrer A, Leopold IH. Duzman E, et al. Am J Ophthalmol. 1982 Sep;94(3):318-27. doi: 10.1016/0002-9394(82)90357-9. Am J Ophthalmol. 1982. PMID: 6751091 Clinical Trial.
Data from two short-term double-masked studies using 24 and 16 subjects suggest that topically applied levobunolol safely and effectively treats open-angle glaucoma and ocular hypertension. The onset of effect of a single drop of 0.5% levobunolol occurred within the …
Data from two short-term double-masked studies using 24 and 16 subjects suggest that topically applied levobunolol safely and effecti …
A cross-over trial comparing once daily levobunolol with once and twice daily timolol.
Akafo SK, Thompson JR, Rosenthal AR. Akafo SK, et al. Eur J Ophthalmol. 1995 Jul-Sep;5(3):172-6. doi: 10.1177/112067219500500305. Eur J Ophthalmol. 1995. PMID: 8845685 Clinical Trial.
The intraocular pressure (IOP) lowering efficacy of once-daily levobunolol 0.5% was compared with timolol 0.5% twice-daily and timolol 0.5% once-daily in 20 chronic open angle glaucoma and 5 ocular hypertensive patients. The design used was a randomised double blind cross- …
The intraocular pressure (IOP) lowering efficacy of once-daily levobunolol 0.5% was compared with timolol 0.5% twice-daily and timolo …
The effect of levobunolol on aqueous humor dynamics.
Yablonski ME, Novack GD, Burke PJ, Cook DJ, Harmon G. Yablonski ME, et al. Exp Eye Res. 1987 Jan;44(1):49-54. doi: 10.1016/s0014-4835(87)80024-6. Exp Eye Res. 1987. PMID: 2881799 Clinical Trial.
We evaluated the acute effects of installation of 0.5% levobunolol on aqueous humor dynamics in a double-masked study in 18 patients with ocular hypertension. ...Aqueous flow decreased approximately 29% in the eyes treated with levobunolol. Total outflow facility an …
We evaluated the acute effects of installation of 0.5% levobunolol on aqueous humor dynamics in a double-masked study in 18 patients …
A combination of levobunolol and dipivefrin for the treatment of glaucoma.
Allen RC, Robin AL, Long D, Novack GD, Lue JC, Kaplan G. Allen RC, et al. Arch Ophthalmol. 1988 Jul;106(7):904-7. doi: 10.1001/archopht.1988.01060140050022. Arch Ophthalmol. 1988. PMID: 3291837 Clinical Trial.
In the groups receiving levobunolol and dipivefrin concurrently, continued intraocular pressure control was achieved equal to that attained with timolol and dipivefrin before study entry. We concluded that concomitant treatment with levobunolol and dipivefrin is equ …
In the groups receiving levobunolol and dipivefrin concurrently, continued intraocular pressure control was achieved equal to that at …
A comparison of the efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD and 0.5% levobunolol hydrochloride BID in patients with ocular hypertension or open-angle glaucoma.
Halper LK, Johnson-Pratt L, Dobbins T, Hartenbaum D. Halper LK, et al. J Ocul Pharmacol Ther. 2002 Apr;18(2):105-13. doi: 10.1089/108076802317373860. J Ocul Pharmacol Ther. 2002. PMID: 12002664 Clinical Trial.
IOP and heart rate (HR) were measured at 3 and 6 weeks after the start of therapy with either timolol gel or levobunolol. Of 133 patients randomized, 116 received both treatments. Timolol gel QD was comparable to levobunolol BID in reducing trough and peak IOP. At t …
IOP and heart rate (HR) were measured at 3 and 6 weeks after the start of therapy with either timolol gel or levobunolol. Of 133 pati …
80 results